Lista de obras - Francois Helle - Dominio Público Uruguay

A Simple and Reliable Strategy for BK Virus Subtyping and Subgrouping

artículo científico publicado en 2017

A new tool to study ribavirin-induced haemolysis

artículo científico publicado en 2012

Alginate hydrogel protects encapsulated hepatic HuH-7 cells against hepatitis C virus and other viral infections

artículo científico publicado en 2014

Anti-Spike, anti-Nucleocapsid and neutralizing antibodies in SARS-CoV-2 hospitalized patients and asymptomatic carriers

artículo científico publicado en 2020

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals

artículo científico publicado en 2020

Apolipoprotein(a) inhibits hepatitis C virus entry through interaction with infectious particles.

artículo científico publicado en 2017

BK Polyomavirus Hijacks Extracellular Vesicles for En Bloc Transmission

artículo científico publicado en 2020

BK polyomavirus in the urine for follow-up of kidney transplant recipients

scientific article published in 2019

Biology of the BKPyV: An Update

artículo científico publicado en 2017

Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry.

artículo científico publicado en 2007

Claudin-1, miR-122 and apolipoprotein E transductions improve the permissivity of SNU-182, SNU-398 and SNU-449 hepatoma cells to hepatitis C virus

artículo científico publicado en 2017

Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro

artículo científico publicado en 2015

Comparative Evaluation of Three Nucleic Acid-Based Assays for BK Virus Quantification

artículo científico publicado en 2015

Comprehensive search for intra- and inter-specific sequence polymorphisms among coding envelope genes of retroviral origin found in the human genome: genes and pseudogenes

artículo científico publicado en 2005

Correction to: The expression of HCV-associated host factors is dependent on the hepatoma cell line used in HCV studies

artículo científico publicado en 2018

Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans

artículo científico publicado en 2006

DHEA prevents ribavirin-induced anemia via inhibition of glucose-6-phosphate dehydrogenase

artículo científico publicado en 2017

Disulfide bonds in hepatitis C virus glycoprotein E1 control the assembly and entry functions of E2 glycoprotein.

artículo científico publicado en 2012

Early steps of the hepatitis C virus life cycle

artículo científico publicado en 2007

Genetic recombination of the hepatitis C virus: clinical implications

artículo científico publicado en 2010

Hepatitis C Virus Resistance to Carbohydrate-Binding Agents

artículo científico publicado en 2016

Hepatitis C virus entry into host cells

artículo científico publicado en 2008

Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein

artículo científico publicado en 2017

High association of T1858-G1896 precore mutations with impaired base pairing and high hepatitis B virus DNA levels in HBeAg-negative chronically infected patients

artículo científico publicado en 2017

Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry.

artículo científico publicado en 2018

Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial

artículo científico publicado en 2008

In vitro infection of primary human hepatocytes by HCV-positive sera: insights on a highly relevant model.

artículo científico publicado en 2013

Indoleamine 2,3-Dioxygenase Is Involved in Interferon Gamma's Anti-BKPyV Activity in Renal Cells

artículo científico publicado en 2020

Initiation of Hepatitis C Virus Infection Requires the Dynamic Microtubule Network: ROLE OF THE VIRAL NUCLEOCAPSID PROTEIN

artículo científico publicado en 2009

Intercellular Transmission of Naked Viruses through Extracellular Vesicles: Focus on Polyomaviruses

scientific article published on 26 September 2020

Natural selection of adaptive mutations in non-structural genes increases trans-encapsidation of hepatitis C virus replicons lacking envelope protein genes.

artículo científico publicado en 2013

No correlation between Torque Teno virus viral load and BK virus replication after kidney transplantation

scientific article published on 01 April 2019

Permissivity of primary human hepatocytes and different hepatoma cell lines to cell culture adapted hepatitis C virus.

artículo científico publicado en 2013

Phylogenetic analysis of a circulating hepatitis C virus recombinant strain 1b/1a isolated in a French hospital centre.

artículo científico publicado en 2015

QuantIF: An ImageJ Macro to Automatically Determine the Percentage of Infected Cells after Immunofluorescence

artículo científico publicado en 2019

Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes

artículo científico publicado en 2015

Risk factors for BK virus viremia and nephropathy after kidney transplantation: A systematic review

scholarly article by Baptiste Demey et al published 12 October 2018 in Journal of Clinical Virology

Risk factors for BK virus viremia and nephropathy after kidney transplantation: A systematic review

Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions

artículo científico publicado en 2010

Simeprevir for the treatment of hepatitis C virus infection

artículo científico publicado en 2014

Strong correlation between liver and serum levels of hepatitis C virus core antigen and RNA in chronically infected patients

artículo científico publicado en 2011

Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus

artículo científico publicado en 2006

The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus Entry

artículo científico publicado en 2008

The Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope Protein

artículo científico publicado en 2007

The antimalarial ferroquine is an inhibitor of hepatitis C virus.

artículo científico publicado en 2013

The end-of-treatment ribavirin concentration predicts hepatitis C virus relapse

artículo científico publicado en 2013

The expression of HCV-associated host factors is dependent on the hepatoma cell line used in HCV studies.

artículo científico publicado en 2013

The hepatitis C virus glycan shield and evasion of the humoral immune response

artículo científico publicado en 2011

The kinase-inhibitor sorafenib inhibits multiple steps of the Hepatitis C Virus infectious cycle in vitro.

artículo científico publicado en 2015

Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection

artículo científico publicado en 2014

Which therapeutic option for hepatitis C virus genotype 1?

artículo científico publicado en 2014

β-Alkylated oligomaltosides as new alternative preservatives: antimicrobial activity, cytotoxicity and preliminary investigation of their mechanism of action

artículo científico publicado en 2013

Lista de obras de Francois Helle

A Simple and Reliable Strategy for BK Virus Subtyping and Subgrouping

A new tool to study ribavirin-induced haemolysis

Alginate hydrogel protects encapsulated hepatic HuH-7 cells against hepatitis C virus and other viral infections

Anti-Spike, anti-Nucleocapsid and neutralizing antibodies in SARS-CoV-2 hospitalized patients and asymptomatic carriers

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals

Apolipoprotein(a) inhibits hepatitis C virus entry through interaction with infectious particles.

BK Polyomavirus Hijacks Extracellular Vesicles for En Bloc Transmission

BK polyomavirus in the urine for follow-up of kidney transplant recipients

Biology of the BKPyV: An Update

Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry.

Claudin-1, miR-122 and apolipoprotein E transductions improve the permissivity of SNU-182, SNU-398 and SNU-449 hepatoma cells to hepatitis C virus

Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro

Comparative Evaluation of Three Nucleic Acid-Based Assays for BK Virus Quantification

Comprehensive search for intra- and inter-specific sequence polymorphisms among coding envelope genes of retroviral origin found in the human genome: genes and pseudogenes

Correction to: The expression of HCV-associated host factors is dependent on the hepatoma cell line used in HCV studies

Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans

DHEA prevents ribavirin-induced anemia via inhibition of glucose-6-phosphate dehydrogenase

Disulfide bonds in hepatitis C virus glycoprotein E1 control the assembly and entry functions of E2 glycoprotein.

Early steps of the hepatitis C virus life cycle

Genetic recombination of the hepatitis C virus: clinical implications

Hepatitis C Virus Resistance to Carbohydrate-Binding Agents

Hepatitis C virus entry into host cells

Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein

High association of T1858-G1896 precore mutations with impaired base pairing and high hepatitis B virus DNA levels in HBeAg-negative chronically infected patients

Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry.

Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial

In vitro infection of primary human hepatocytes by HCV-positive sera: insights on a highly relevant model.

Indoleamine 2,3-Dioxygenase Is Involved in Interferon Gamma's Anti-BKPyV Activity in Renal Cells

Initiation of Hepatitis C Virus Infection Requires the Dynamic Microtubule Network: ROLE OF THE VIRAL NUCLEOCAPSID PROTEIN

Intercellular Transmission of Naked Viruses through Extracellular Vesicles: Focus on Polyomaviruses

Natural selection of adaptive mutations in non-structural genes increases trans-encapsidation of hepatitis C virus replicons lacking envelope protein genes.

No correlation between Torque Teno virus viral load and BK virus replication after kidney transplantation

Permissivity of primary human hepatocytes and different hepatoma cell lines to cell culture adapted hepatitis C virus.

Phylogenetic analysis of a circulating hepatitis C virus recombinant strain 1b/1a isolated in a French hospital centre.

QuantIF: An ImageJ Macro to Automatically Determine the Percentage of Infected Cells after Immunofluorescence

Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes

Risk factors for BK virus viremia and nephropathy after kidney transplantation: A systematic review

Risk factors for BK virus viremia and nephropathy after kidney transplantation: A systematic review

Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions

Simeprevir for the treatment of hepatitis C virus infection

Strong correlation between liver and serum levels of hepatitis C virus core antigen and RNA in chronically infected patients

Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus

The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus Entry

The Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope Protein

The antimalarial ferroquine is an inhibitor of hepatitis C virus.

The end-of-treatment ribavirin concentration predicts hepatitis C virus relapse

The expression of HCV-associated host factors is dependent on the hepatoma cell line used in HCV studies.

The hepatitis C virus glycan shield and evasion of the humoral immune response

The kinase-inhibitor sorafenib inhibits multiple steps of the Hepatitis C Virus infectious cycle in vitro.

Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection

Which therapeutic option for hepatitis C virus genotype 1?

β-Alkylated oligomaltosides as new alternative preservatives: antimicrobial activity, cytotoxicity and preliminary investigation of their mechanism of action